U.S. Markets closed

MediPharm Labs Corp. (MEDIF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2190-0.0076 (-3.35%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.2266
BidN/A x N/A
AskN/A x N/A
Day's Range0.2100 - 0.2266
52 Week Range0.2100 - 0.7850
Avg. Volume150,736
Market Cap57.168M
Beta (5Y Monthly)0.74
PE Ratio (TTM)N/A
EPS (TTM)-0.3310
Earnings DateNov 11, 2021 - Nov 17, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Cannabis Industry Investor Presentations Now Available for On-Demand Viewing

    Virtual Investor Conferences® and KCSA Strategic Communications today announced that the presentations from the September 8th & 9th Cannabis Industry Virtual lnvestor Conference are now available for on-demand viewing at VirtualInvestorConferences.com.

  • GlobeNewswire

    Insomnia Treatment Study using MediPharm Labs CBD50 Product to Proceed to Phase 2 with Health Canada Consent

    McMaster University researchers using MediPharm Labs’ CBD50 formula and a CBD:THC 10:2 formulation, which has the same cannabinoid ratio as MediPharm Labs’ CBD25:, have received a No Objection Letter from Health Canada to begin recruiting human subjects for a placebo-controlled trial using cannabis- oil for treatment of insomnia in major depressive disorder. Among those with depression, 75% have difficulty falling or staying asleep - according to John Hopkins Medicine. MediPharm Labs and the McM

  • GlobeNewswire

    MediPharm Labs Australia Receives Government Grant to Assist with International Expansion

    Received first instalment of a government grant for $330,000AUD as part of the Australian government’s Manufacturing Modernisation program aimed at supporting manufacturers scaling their businesses.Grant to be used for automation of downstream manufacturing and scaling purification abilities.Government grant as part of broader manufacturing sector funding demonstrates the backing of the medical cannabis industry by the Australian federal government and recognition of MediPharm Labs Australia’s r